Microba Life Sciences Ltd (ASX: MAP) has debuted on the ASX following IPO raising $30m
Microba Life Sciences Ltd (ASX: MAP) has debuted on the Australian stock exchange today.
Following an IPO at $0.45/share raising $30 million, shares in the precision microbiome science medical innovation company fell 24.45% to close its debut session at $0.34/share.
An increase in listing price is a vote of confidence from the market about the future prospects of the company.
A decrease in the listing price can be interpreted in a number of ways, including whether the IPO was accurately priced.
Read the full story
in the Grafa app
To read the full article and more in the Grafa app, available on all app stores.
Track the trends
Get the hot tips first
Stay close to your investments
Learn to trade like a pro
Let your money entertain you
See more stories like this
48% of businesses say they will not raise prices, primarily due to the desire to...read more